Measles-containing-vaccine second-dose (MCV2) … MCV2, WUENIC in Myanmar
Myanmar: Measles-containing-vaccine second-dose (MCV2) immunization coverage was 68.0% in 2025. ◆ Volatile
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Myanmar, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, measles-containing-vaccine second-dose (mcv2) immunization coverage in Myanmar stood at 68.0%.
The figure is down 12.8% over ten years.
Over the whole period, measles-containing-vaccine second-dose (mcv2) immunization coverage in Myanmar peaked at 90.0% in 2020 and was at its lowest, 0.0%, in 2000.
That places Myanmar 141st out of 194 countries with data for 2025, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Myanmar, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 0.0% | — |
| 2007 | 0.0% | — |
| 2008 | 57.0% | — |
| 2009 | 65.0% | +14.0% |
| 2010 | 75.0% | +15.4% |
| 2011 | 80.0% | +6.7% |
| 2012 | 76.0% | -5.0% |
| 2013 | 80.0% | +5.3% |
| 2014 | 82.0% | +2.5% |
| 2015 | 78.0% | -4.9% |
| 2016 | 86.0% | +10.3% |
| 2017 | 80.0% | -7.0% |
| 2018 | 87.0% | +8.8% |
| 2019 | 80.0% | -8.0% |
| 2020 | 90.0% | +12.5% |
| 2021 | 42.0% | -53.3% |
| 2022 | 64.0% | +52.4% |
| 2023 | 66.0% | +3.1% |
| 2024 | 68.0% | +3.0% |
| 2025 | 68.0% | +0.0% |
Myanmar compared with similar countries
- Myanmar's 68.0% is below the median for lower middle income countries, which is 70.0%, 97% of the median. (47 countries reporting)
- Myanmar's 68.0% is below the median for East Asia & Pacific, which is 78.0%, 87% of the median. (30 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 12.2% | 0.0% | 65.0% | 10 |
| 2010s | 80.4% | 75.0% | 87.0% | 10 |
| 2020s | 66.3% | 42.0% | 90.0% | 6 |
Countries ranked near Myanmar
More health data for Myanmar
- Un projection of annual infant deaths, annual growth rate -2.11 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.1576 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,398 deaths per 1,000 people (2090)
- Number of infants who die before age 1 2,973 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 7 (2025)
- Population ages 00-04, female, annual growth rate -0.759 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0387 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.8351 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is measles-containing-vaccine second-dose (mcv2) immunization coverage in Myanmar?
- Measles-containing-vaccine second-dose (mcv2) immunization coverage in Myanmar was 68.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Myanmar?
- The highest recorded value was 90.0% in 2020.
- What is the lowest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Myanmar?
- The lowest recorded value was 0.0% in 2000.
- How does Myanmar rank for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Myanmar ranks 141st out of 194 countries with data for 2025.
- Is measles-containing-vaccine second-dose (mcv2) immunization coverage rising or falling in Myanmar?
- Over the last ten years it is down 12.8%. The long-run trend across the full record is volatile.
- Where does this Myanmar data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).